
CDMO - October 9, 2023
Column: Playing it safe in manufacturing of advanced biologics
The very title of this article is probably a contradiction in terms. There are few other industries where manufacturing is more complex than for advanced biologics – the kind of drugs and treatments that build upon cell and gene therapies, and tissue engineered products. The manufacturing process, once you are ready for human clinical studies, […]